Literature DB >> 17130897

Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection.

Andrew R Lloyd1, Emma Jagger, Jeffrey J Post, Lee-Ann Crooks, William D Rawlinson, Young S Hahn, Rosemary A Ffrench.   

Abstract

Individuals infected with hepatitis C virus (HCV) have two possible outcomes of infection, clearance or persistent infection. The focus of this review is the host mechanisms that facilitate clearance. The interaction between HCV viral components and the immune system ultimately determines the balance between the virus and host. Strong evidence points to the aspects of cellular immune response as the key determinants of outcome. The recent discovery of viral evasion strategies targeting innate immunity suggests that the interferon-alpha/beta induction pathways are also critical. A growing body of evidence has implicated polymorphisms in both innate and adaptive immune response genes as determinants of viral clearance in individuals infected with HCV.

Entities:  

Mesh:

Year:  2006        PMID: 17130897     DOI: 10.1038/sj.icb.7100010

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  21 in total

Review 1.  Viral subversion mechanisms in chronic kidney disease pathogenesis.

Authors:  Leslie A Bruggeman
Journal:  Clin J Am Soc Nephrol       Date:  2007-07       Impact factor: 8.237

2.  The swinging thyroid in hepatitis C infection and interferon therapy.

Authors:  Huy A Tran
Journal:  BMJ Case Rep       Date:  2009-09-15

3.  The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.

Authors:  Phillip S Pang; Paul J Planet; Jeffrey S Glenn
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

Review 4.  Host genetic factors and antiviral immune responses to hepatitis C virus.

Authors:  Chloe L Thio
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

Review 5.  Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.

Authors:  Juan R Larrubia; Selma Benito-Martínez; Miryam Calvino; Eduardo Sanz-de-Villalobos; Trinidad Parra-Cid
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

6.  Interactive effects of immunoglobulin gamma and human leucocyte antigen genotypes on clearance and persistence of infection with hepatitis C virus.

Authors:  J P Pandey; M A Montes-Cano; J Aguilar-Reina; M F Gonzalez-Escribano
Journal:  Clin Exp Immunol       Date:  2007-10-09       Impact factor: 4.330

7.  Hepatitis C virus core protein discriminates between the two IgG2 allotypes.

Authors:  Aryan M Namboodiri; Paul J Nietert; Janardan P Pandey
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

Review 8.  Immune responses during acute and chronic infection with hepatitis C virus.

Authors:  Shigeaki Ishii; Margaret James Koziel
Journal:  Clin Immunol       Date:  2008-06-02       Impact factor: 3.969

9.  The Spectrum of Autoimmune Thyroid Disease in the Short to Medium Term Following Interferon-alpha Therapy for Chronic Hepatitis C.

Authors:  Huy A Tran; Glenn E M Reeves
Journal:  Int J Endocrinol       Date:  2009-08-31       Impact factor: 3.257

10.  Study of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune response.

Authors:  Julien Pothlichet; Anne Burtey; Andriy V Kubarenko; Gregory Caignard; Brigitte Solhonne; Frédéric Tangy; Meriem Ben-Ali; Lluis Quintana-Murci; Andrea Heinzmann; Jean-Daniel Chiche; Pierre-Olivier Vidalain; Alexander N R Weber; Michel Chignard; Mustapha Si-Tahar
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.